Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.6 USD | -1.76% | +0.47% | -9.84% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.84% | 3.43B | |
+4.66% | 32.45B | |
+12.62% | 7.26B | |
+21.71% | 3.84B | |
-25.99% | 1.31B | |
-35.53% | 1.11B | |
+2.48% | 919M | |
-23.74% | 856M | |
-39.85% | 840M | |
-16.77% | 712M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Transcript : Evolent Health, Inc., Q4 2021 Earnings Call, Feb 23, 2022